ANXA1 and stroke disorder: By disrupting the SIRT5–ANXA1 interaction and facilitating SIRT5 clearance, this strategy enhances ANXA1 membrane localization and secretion, ultimately reducing infarct volume, preserving neuronal integrity, and improving neurological outcomes in stroke models—all without apparent toxicity [154].